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1. Introduction 
Phlorizin, a known inhibitor of D-glucose transport, 
has been used as a tool to study transport and binding 
characteristics of sugars in the kidney tubule. The 
binding of phlorizin to kidney brush border mem- 
branes was first characterized byKinne et al. [ 1,2]. 
They and others [3] have demonstrated the compet;- 
tive inhibition of phlorizin binding by D-glucose and 
used this technique to study the characteristics of 
D-glucose binding. On the basis of physiological stud- 
ies in dogs [4], it has been proposed that the phlori- 
zin inhibition of D-glucose transport at the luminal 
surface is competitive while that at the antiluminal 
surface of the tubular cell is not. We have demonstra- 
ted the binding of [a H]phlorizin to a rat kidney mem- 
brane preparation enriched for antiluminal membra- 
nes. This binding is not affected by D-glucose and 
must be termed 'non-specific'. The binding observed 
is reversible and membrane bound [aH] phlorizin may 
be dissociated by high concentrations of phlorizin 
and resorcinol. 
2. Materials and methods 
Adult male Sprague-Dawley rats fed ad libitum 
on Purina rat chow and water were sacrificed and the 
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kidneys removed. All operations were performed at 
4°C. Hasma membranes were isolated by differential 
centrifugation using the method of Fitzpatrick et al. 
[5] in a slightly modified form. Whole decapsulated 
kidneys were sliced with a Stadie-Riggs microtome 
and the slices homogenized in 3 × the volume of SEA 
buffer (0.25 M sucrose, 0.005 M EDTA, 726 units] 
ml penicillin G, 64/lg]ml streptomycin sulfate, and 
140 mM NaC1, pH 7.4). The final pellet was suspended 
in SEA buffer. 
The binding assay was patterned after that of 
Bode et al. [1]. It consisted of 0.5 ml of freshly 
prepared membranes (0.2-2.0 mg/ml) in SEA buffer 
at 22°C to which 0.2/aCi [a H] phlorizin and 0.2 ~tCi 
D- [l 4 C] mannose were added. Unlabeled phlorizin was 
added to the concentration desired. For competition 
experiments, the membranes were suspended in SEA 
containing I00 mM D-glucose or 100 mM resorcinol 
for use in the binding assay. The mixture was stirred 
on a Vortex genie for 1/2 min and then centrifuged 
at 20 000 g for 20 min at 0°C. The supernatants were 
removed and excess liquid wiped from the walls of 
the centrifuge tube using Kimwipes. The membrane 
pellets were solubilized in 1 ml Soluene 100 (Packard) 
and counted in 10 ml dilute Liquifluor (Packard) in 
a Packard Tri-Carb scintillation counter. Counting 
efficiency and crossover values were determined 
using the automatic external standard. 
The amount of phlorizin bound (b) was calculated 
after using mannose to correct for diffusion. 'Free' 
(30 phlorizin was calculated from the expression 
f=  T -b  where Tis the total amount of phlorizin in 
the incubation mixture. Bound phlorizin was then 
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converted to pmoles/mg of protein to compare dif- 
ferent preparations. The expressions b/f and b are 
given per mg of protein throughout. Protein concen- 
tration was determined by the method of Lowry et 
al. [6]. 
To determine if the phlorizin bound could be dis- 
placed, standard binding assays were performed after 
which the membrane pellets were resuspended in SEA 
buffer alone or in SEA buffer containing either 1 mM 
unlabeled phlorizin, I00 mM D-glucose, or 100 mM 
resorcinol. After thorough resuspension, the pellets 
were allowed to incubate for 5 min at 22°C before 
re-centrifugation at 20 000g for 20 min at 0°C. 
Pellets were then treated as described above. 
3. Results and discussion 
The binding of [ 3 H] phlorizin to rat renal plasma 
membranes was studied over a concentration range 
of 0.04/aM-10.4/IM. As can be seen in fig. 1, phlori- 
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Fig. 1. Effect of phlorizin concentration  phlorizin bind- 
hag to rat renal plasma membranes. Plasma membranes were 
incubated under standard binding assay conditions in SEA 
buffer containing 0.2/~Ci [3 H] phlorizin with the addition of 
unlabeled phlorizin to the desired concentration. The final 
concentrations of phlorizin varied from 0.04 #M-10.04 
/~M. Assays were performed inthe absence (o) and presence 
of 100 mM D-glucose (zx) or 100 mM resoreinol (e). Each 
point represents the mean of 21-35 determinations from 
7-12 different preparations. One standard error from the 
mean is indicated. 
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Fig. 2. A Scatchard plot of phlorizin binding to rat renal 
plasma membranes. Data from fig. 1.derived from the stan- 
dard assay with no additions of glucose or resorcinol are 
shown. Each point represents the mean of 21-35 determi- 
nations from 7-12 different membrane preparations. 
zin binding was not saturable over this range. Addition 
of 100 mM D-glucose or 100 mM resorcinol in the 
binding assay produced no significant inhibition of 
phlorizin binding. Resorcinol resembles the phenolic 
portion of the phlorizin molecule and was used to see 
if the phlofizin binding observed might involve the 
phenolic site. In fig. 2, a Scatchard plot of the data 
shows a biphasic urve which indicates the presence of 
two different binding sites. Neither binding site was 
affected by the presence of I00 mM D-glucose or 
100 mM resorcinol. 
Results from studies in which pellets with bound 
[3H] phlorizin were resuspended in buffer or buffer 
containing 1mM phiorizin, 100 mM D-glucose, or 
100 mM resorcinol are shown in fig. 3. The amount of 
[3 H] phlorizin bound per milligram of protein to plas- 
ma membrane preparations, was not decreased by 
'washing' (resuspension a d re-centrifugation) of the 
pellet in SEA buffer or in SEA buffer containing 
100 mM D-glucose. However, pellets from the binding 
assay which were resuspended in SEA containing 1mM 
unlabeled phlorizin or 100 mM resorcinol did exhibit 
displacement of the bound material to different 
extents. Approximately 30% of the [3 H] phiorizin 
bound was displaced by resuspension of the pellets 
in 1 mM unlabeled phlorizin while about 40% of the 
membrane bound phlorizin was removed by subse- 
quent exposure to 100 mM resorcinol. 
It would seem that, although the phlorizin binding 
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Fig. 3. Displacement of membrane-bound phlorizin. Standard 
binding assays were performed after which membrane pellets 
were resuspended in SEA buffer alone (o) or in SEA con- 
taining 1 mM unlabeled phlorizin (o), 100 mM D-glucose 
(~), or 100 mM resorcinol (.). The resuspended pellets were 
then re-centrifuged and [3 H] phlorizin bound per nag protein 
determined. Each point represents he mean of triplicate 
determinations from a single plasma membrane preparation. 
The abscissa shows the original concentration of phlorizin 
in the standard binding assay. 
one of these sites, designated R1, was considered 
to exhibit 'specific' binding which was inhibited by 
D-glucose, similar to the R1 site described by Frasch 
et al. [2]. The relative purification factor for the un- 
specific site (R3) was seen to decrease during brush 
border isolation. They do not elaborate on their R2 
site. The membrane preparations u ed in the present 
study showed a 6-fold to 8-fold purification of Na~K ÷- 
ATPase and a 2-fold purification of alkaline phospha- 
tase over that in the homogenate, indicating enrich- 
ment for basal or antiluminal over microvillar mem- 
branes. We have shown that 'non-specific' phlorizin 
binding sites (perhaps R2 and R3) occur in rat renal 
plasma membranes and that the 'specific' R1 site of 
Frasch et al. and of Glossman and Neville is not 
present in a plasma membrane preparation enriched 
for antiluminal membranes. 
The physiological significance of phlorizin binding 
is not yet fully understood. Investigators working 
with kidney brush border membranes have inferred 
the presence of three binding sites, however, the 
specificity of these sites is far from clear. Others 
have shown phlorizin-glucose interaction at one site 
(R1) on the luminal membrane, but we have demon- 
strated no such interaction using preparations en- 
riched for antiluminal membranes. While phlorizin 
binds to these membranes, the binding must be ter- 
med 'non-specific' for the present since it may eventu- 
ally be found to relate to effects of phlorizin on pro- 
cesses other than sugar transport. 
observed is reversible to some extent, dissociation 
of the bound material from the membrane is relatively 
difficult. Bound [3 H] phlorizin can, however, be dis- 
sociated by high concentrations of phlorizin or resor- 
cinol. No significant effect of D-glucose can be ob- 
served on the binding of [31-1] phlorizin to or dissocia- 
tion of bound [3 H] phlorizin from plasma membranes. 
This supports the proposal of Silverman et al. [4], deri- 
ved from in vivo studies in dog kidney, that phlorizin 
binding to antiluminal membranes does not involve 
competitive inhibition with D-glucose. 
These results reflect what has been called 'non- 
specific' binding of phlorizin to the membrane. Gloss- 
man and Neville [3] have proposed the existence of 
three separate sites to explain their data for phlorizin 
binding to rat renal brush border membranes. Only 
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